{"company":{"id":2138905,"name":"Abzena","domain":"abzena.com","url":"https://alion.io/company/abzena"},"section":"news","answer":"Abzena: 5 headlines on record, 0 headlines in the last 90 days. Its story counts 5 milestones.","figures":[{"label":"Headlines","value":"5"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"5"}],"blocks":[{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":5}],"story":[{"title":"Launched Abzena Launches LabZient, an Analytical Platform to Expedite the Path to IND for Antibodies · PRNewswire","url":"https://prnewswire.com/news-releases/abzena-launches-labzient-an-analytical-platform-to-expedite-the-path-to-ind-for-antibodies-302056321.html"},{"title":"Partnership Abzena partners with FDA on publication demonstrating the benefits of the MAPPs assay for immunogenicity · medindia.net","url":"https://medindia.net/health-press-release/abzena-partners-with-fda-on-publication-demonstrating-the-benefits-of-the-mapps-assay-for-immunogenicity-660214-1.htm"},{"title":"Raised a round Venture round $65M","url":"https://fiercepharma.com/pharma/abzena-nabs-65m-quest-become-most-scientifically-adept-partner-research-organization"},{"title":"Won a customer Abzena Selected by Immunome to Develop and Manufacture Antibody Cocktail for Immunome's COVID-19 Antibody Based Treatment · Nasdaq","url":"https://nasdaq.com/press-release/abzena-selected-by-immunome-to-develop-and-manufacture-antibody-cocktail-for"},{"title":"Founded"}],"as_of":"2026-11-19","cite":"Abzena, News. Alion, Nov 19, 2026. https://alion.io/company/abzena/news","html_url":"https://alion.io/company/abzena/news","json_url":"https://alion.io/company/abzena/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-19T03:42:44Z"}}